Research Into Biomarkers Predictive of Survival and Response to Cancer Treatment
ConditionCancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCentre Antoine Lacassagne
About this trial
Research into biomarkers predictive of survival and response to cancer treatment
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patient having a blood test, venous line insertion or injection on an implantable venous device scheduled as part of their standard care,
Patient who has read the information note and stated that he/she has no objections
Patient who has not objected to the use of this data for medical research purposes
Patient with social security cover.
Disqualifiers
Patient already included in the study
Patient considered to be a vulnerable person; vulnerable persons are defined in article L1121-5 to -8
Trial population
Patients with cancer receiving care at Centre Antoine Lacassagne are prospectively recruited for biospecimen collection during routine clinical blood sampling.
Trial design
Design model
Other
Time perspective
Prospective
Treatments tested in this trial
blood sampling
Other intervention36ml of blood will be taken during a blood sampling performed in standard practice
Treatment groups
40,000 Participants
are divided into 1 treatment groupGroup A: principal1 intervention
Trial outcomes
Primary outcomes
1
Prediction
The aim of this project is to make a biobank in prevision of MR004 sub-projects which define specific biomarkers studied to identify biomarkers predictive of response.
Time frame
day 1Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov